![Alfredo Zurlo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alfredo Zurlo
Nessuna posizione attualmente
Profilo
Alfredo Zurlo served as Co-Managing Director at Glycotope GmbH.
He then worked as Chief Medical Officer at MOLOGEN AG from 2013 to 2016.
After that, he served as Chief Medical Officer at Scandion Oncology A. Zurlo holds a doctorate degree from The American University of Rome.
Precedenti posizioni note di Alfredo Zurlo
| Società | Posizione | Fine |
|---|---|---|
| MOLOGEN AG | Direttore Tecnico/Scientifico/R&S | 31/03/2016 |
| SCANDION ONCOLOGY A/S | Direttore Tecnico/Scientifico/R&S | - |
Glycotope GmbH
 Glycotope GmbH Data Processing ServicesTechnology Services Provides hosting, web development and UX design services | Amministratore Delegato | - |
Formazione di Alfredo Zurlo
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
5
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
The American University of Rome
 The American University of Rome Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MOLOGEN AG
 MOLOGEN AG Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immunotherapies for the treatment of infectious diseases | Health Technology |
Glycotope GmbH
Glycotope GmbH Data Processing ServicesTechnology Services Provides hosting, web development and UX design services | Technology Services |
Scandion Oncology A/S
 Scandion Oncology A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for chemotherapy resistance mechanisms | Health Technology |
